Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at SEK 879.3B, ahead of Johnson & Johnson (SEK 829.2B) and Sanofi (SEK 805.3B). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerSEK 879.3B
- Median
- SEK 8.9B
- Combined market value
- SEK 52.02T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SEK 879.3B | SEK 1.64T | SEK 287.48 | 0.66% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SEK 829.2B | SEK 6.76T | SEK 2,806.81 | 1.00% down | 38% up | ||
| 3 | SanofiSNY · Health Care | SEK 805.3B | SEK 1.16T | SEK 481.02 | 0.47% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | SEK 534.9B | SEK 3.54T | SEK 1,437.19 | 1.44% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | SEK 530.1B | SEK 1.84T | SEK 1,064.72 | 2.55% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | SEK 494.9B | SEK 2.84T | SEK 1,829.08 | 1.28% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | SEK 473.1B | SEK 697.2B | SEK 218.21 | 0.85% down | 54% up | ||
| 8 | NovartisNVS · Health Care | SEK 469.1B | SEK 3.01T | SEK 1,596.22 | 1.37% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | SEK 317.8B | SEK 1T | SEK 9,681.55 | 0.59% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | SEK 292.8B | SEK 1.8T | SEK 408.26 | 1.36% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | SEK 269.8B | SEK 12.74T | SEK 14,306.20 | 0.60% down | 35% up | ||
| 12 | GSKGSK · Health Care | SEK 221B | SEK 997.1B | SEK 497.43 | 0.62% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | SEK 189.8B | SEK 1.37T | SEK 5,406.54 | 0.47% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | SEK 187.8B | SEK 1.26T | SEK 617.62 | 1.04% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | SEK 149.6B | SEK 239B | SEK 208.45 | 0.24% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | SEK 98.8B | SEK 400.1B | SEK 695.77 | 0.37% down | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 80.4B | SEK 508.7B | SEK 435.97 | 0.62% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | SEK 72.2B | SEK 251.9B | SEK 5,915.36 | 0.40% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | SEK 66.6B | SEK 131.2B | SEK 262.44 | 0.15% down | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | SEK 61.9B | SEK 114.8B | SEK 592.71 | 0.38% down | 11% up | ||
| 21 | GrifolsGRFS · Health Care | SEK 59.5B | SEK 59.3B | SEK 87.14 | 0.70% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | SEK 59.5B | SEK 323.3B | SEK 524.38 | 0.75% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | SEK 46B | SEK 284.7B | SEK 392.90 | 0.18% down | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | SEK 44.3B | SEK 472.5B | SEK 4,136.30 | 1.57% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 43.9B | SEK 156.7B | SEK 2,441.41 | 0.25% down | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 40.8B | SEK 125.2B | SEK 150.19 | 0.20% down | 5% up | ||
| 27 | ZoetisZTS · Health Care | SEK 33.9B | SEK 340.3B | SEK 837.51 | 1.34% down | 29% down | ||
| 28 | AlkermesALKS · Health Care | SEK 18.5B | SEK 77.9B | SEK 463.78 | 0.35% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | SEK 10.3B | SEK 60.3B | SEK 3,012.57 | 0.84% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | SEK 10.2B | SEK 31.9B | SEK 164.22 | 0.25% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | SEK 8.9B | SEK 86.6B | SEK 3,097.06 | 0.16% down | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | SEK 8B | SEK 211.8B | SEK 1,581.68 | 0.61% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | SEK 7.8B | SEK 65.1B | SEK 1,603.75 | 0.00% | 31% up | ||
| 34 | InsmedINSM · Health Care | SEK 7.5B | SEK 269.9B | SEK 1,230.37 | 0.71% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | SEK 7.3B | SEK 91B | SEK 957.75 | 0.41% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | SEK 6.7B | SEK 84.5B | SEK 105.70 | 2.58% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | SEK 6.6B | SEK 96B | SEK 635.01 | 0.41% down | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | SEK 6.6B | SEK 78.8B | SEK 719.76 | 1.02% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | SEK 6.5B | SEK 49.8B | SEK 286.03 | 1.01% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | SEK 6.3B | SEK 82.7B | SEK 1,266.36 | 0.10% down | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.1B | SEK 99.5B | SEK 4,282.13 | 0.20% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 5.8B | SEK 75.7B | SEK 963.50 | 0.37% down | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | SEK 5.3B | SEK 47.1B | SEK 430.12 | 0.62% up | 88% up | ||
| 44 | ABIVAXABVX · Health Care | SEK 5.1B | SEK 73.9B | SEK 843.97 | 1.10% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | SEK 5B | SEK 48.7B | SEK 865.22 | 2.17% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | SEK 5B | SEK 45.3B | SEK 272.05 | 0.76% down | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | SEK 4.8B | SEK 66.2B | SEK 975.34 | 0.42% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 4.7B | SEK 61.5B | SEK 435.00 | 0.49% down | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | SEK 3.4B | SEK 40.6B | SEK 296.91 | 0.61% down | 169% up | ||
| 50 | ErascaERAS · Health Care | SEK 3.3B | SEK 49.8B | SEK 141.95 | 0.50% up | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | SEK 3.2B | SEK 60.8B | SEK 930.71 | 0.46% down | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.4B | SEK 81.6B | SEK 1,176.68 | 0.76% down | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | SEK 1.2B | SEK 49.4B | SEK 514.97 | 0.89% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | SEK 897.8M | SEK 73B | SEK 1,387.97 | 0.40% up | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -SEK 719.9M | SEK 74.8B | SEK 214.75 | 0.00% | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -SEK 1.2B | SEK 54.3B | SEK 1,285.94 | 0.46% up | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -SEK 1.8B | SEK 179.1B | SEK 2,729.84 | 1.00% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -SEK 2.1B | SEK 50.9B | SEK 608.68 | 0.83% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -SEK 6.7B | SEK 73.5B | SEK 527.74 | 0.48% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -SEK 21.2B | SEK 151.5B | SEK 777.88 | 0.39% down | 17% up | ||
| 61 | AbbVieABBV · Health Care | -SEK 33.3B | SEK 5.21T | SEK 2,947.79 | 1.01% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1683 SEK).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (SEK 879.3B), Johnson & Johnson (SEK 829.2B) and Sanofi (SEK 805.3B) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 14:31 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of SEK 52.02T as of 18 Nov 2026, 14:31 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.